Back to all issues
Reference Range WeeklyIssue 7
A house at dusk under a crescent moon, with faint air currents near its lower windows and fermenting jars among microbe-like shapes in the garden soil.

An earlier bedtime, a radon surprise, and a bladder-pill twist

Several studies this week tested something many people already take for granted. Most came back with a different answer than expected. One turned up its most interesting result while looking for something else.

  • Randomized trial
  • 196 short sleepers with prediabetes
  • 8 weeks

Most sleep advice is about hours. An NYU trial found that, for weight, the clock may have mattered more.

The researchers enrolled 196 adults aged 21 to 64 who slept less than 6.5 hours a night and had prediabetes, meaning blood sugar above normal but below the diabetes range. Everyone got an eight-week lifestyle program. Half also got sleep coaching. The coached group moved their sleep earlier and reported better sleep and less daytime drowsiness.

The main target, blood sugar, didn't change in either group.

The surprise came when the team looked across all participants together. Each hour earlier that people fell asleep went with about 1.3 pounds (0.6 kg) of extra weight loss over the eight weeks, whatever their total sleep.

That link comes from comparing people, not from randomly assigning bedtimes. It can't show that going to bed earlier caused the weight loss. The program was short, the sample modest, and many people can't shift their schedules because of work, family or their own biology. Whether bedtime itself moves weight is now a question a trial could test directly.

Read the original source · Nursing Research

Published November 9, 2026

  • Observational study
  • 6,803 Japanese adults

People eat yogurt, natto or kimchi hoping to add good bacteria to their gut. A large Japanese study suggests any benefit may work another way.

Researchers analyzed the microbial DNA in stool samples from 6,803 adults in Japan's 4D cohort. The gut microbes sorted along two opposing directions. One leaned toward health and featured butyrate producers, bacteria such as *Faecalibacterium prausnitzii* that make a compound called butyrate. The other leaned toward disease. It included bacteria that usually live in the mouth or are associated with pathogens, and it tracked with higher levels of inflammatory signaling molecules. Together, the two directions linked lifestyle to overall health and to 15 chronic diseases.

Vegetables, fruit, mushrooms, natto, coffee and physical activity lined up with the health side. Refined carbohydrates, soft drinks and smoking lined up with the disease side, and long hours of sitting went with a higher disease score.

Fermented foods landed on the health side, but not through their own microbes. Those showed no meaningful mediating role. The link ran through bacteria already in the gut, such as the butyrate producers. Fermented foods may favor the residents rather than add newcomers.

This is observational data, so it can't prove the microbes cause the health differences. A microbiome score reproduced in 11 of 13 outside cohorts, covering 3,095 people in several countries. Some details come from the university's press release because the journal article could not be opened.

Read the original source · Nature Medicine
  • Observational study
  • 43,188 postmenopausal women
  • mean 16.2 years

Radon is an invisible, odorless gas best known for raising lung cancer risk. A study of more than 43,000 women suggests it may also be tied to the heart.

The researchers drew on the Women's Health Initiative. They followed 43,188 postmenopausal women, aged 50 to 79 when they enrolled in the 1990s, for an average of 16.2 years. Each woman's indoor radon exposure was estimated from the level in her county. Over that time, there were 3,446 heart failure hospitalizations.

The raw counts rose with radon. Per 1,000 women, there were 68 cases in counties below 2 picocuries per liter (pCi/L, the usual unit for radon), 79 between 2 and 4, and 101 above 4. After adjusting for other factors, women in the highest-radon counties had a 19% higher risk than those in the lowest. The middle group's difference was not statistically significant. The authors sized the top group's extra risk as roughly equal to a 16 mm Hg rise in systolic blood pressure, the top number in a reading. The link was stronger in women who had ever smoked.

The weak spot is the exposure measure. A county average can differ a lot from what one house holds, and smoking was recorded only as ever or never. The findings apply to older women, not men or younger adults. Radon can be measured and reduced, but nobody knows yet whether lowering it would protect the heart.

Read the original source · JAMA Network Open
  • Randomized trial
  • 445 frail or multimorbid older adults
  • average 4.5 years

When an older person's kidneys fail, many families assume dialysis comes next. Dialysis does the kidneys' job of filtering the blood and usually means several hospital sessions a week. A UK trial asked whether, for the frailest patients, planning for it leads to better lives.

The Prepare for Kidney Care trial, published in The Lancet, enrolled 445 people from 31 UK kidney centres, about half of the country's kidney services. About three in four were 80 or older. The rest were 65 to 79 with other health problems. Each person was randomly assigned to prepare either for dialysis or for 'responsive management', a structured form of kidney care without dialysis. They were followed for an average of 4.5 years.

Neither plan came out ahead when length and quality of life were weighed together. Only 28% of those preparing for dialysis ever started it. In both groups, people were more likely to die from other causes than to reach the point of needing dialysis.

It is the first randomized trial of its kind, and it covers a narrow group: older people with kidney failure plus frailty or several conditions. It says nothing about people already on dialysis or younger, fitter patients. Everyone knew which plan they were on. The public summaries also leave out the detailed survival and quality-of-life figures, so how the two paths differed day to day is not yet clear.

Read the original source · The Lancet
  • Observational study
  • 830,393 adults newly treated for overactive bladder

For years, a family of overactive bladder pills has carried a dementia warning. A study of more than 830,000 people found the newer alternative was not linked to less dementia. The small gap that did appear leaned the other way.

The older drugs, called anticholinergics, include oxybutynin. Doctors have increasingly switched patients to a newer class, beta-3 agonists such as mirabegron. The researchers searched Epic Cosmos, a large pool of electronic health records. They identified 830,393 adults aged 40 to 90 who started treatment for overactive bladder between 2012 and 2025 and had no dementia at the start. Most, 572,489, began on an anticholinergic the team classed as high-risk. Another 49,592 began on a lower-risk one, and 208,312 on a beta-3 agonist. Over the follow-up, 65,134 were diagnosed with dementia.

People who get different drugs often differ in other ways, so the team weighted the groups to make them more comparable. Estimated 10-year dementia rates came out at 20.0% for the newer drugs, 19.0% for the lower-risk older drugs and 18.1% for the high-risk ones. The high-risk group's slightly lower risk was statistically clear. The lower-risk group did not differ from the newer drugs.

The authors don't take this as evidence that the older pills protect the brain. Their likelier explanation is who gets prescribed what. If doctors steer patients they already worry about toward the newer drug, that group will show more dementia whatever the pill does. Researchers call this confounding by indication.

They also checked how fragile the result is with E-values, which estimate how strong a hidden factor would need to be to erase a finding. The values were 1.29 and 1.20. Modest unmeasured confounding could explain the differences.

The records showed prescriptions ordered, not pills taken, and doses were mostly missing. Dementia came from diagnosis codes or dementia medications, which can miss early disease. Subgroup results were inconsistent.

The study does not show the older drugs are safe for the brain. It does undercut the expectation that switching to the newer class lowers dementia risk.

Read the original source · JAMA Network Open

Five more worth your time

  1. A drug plus vibration nudged brain proteins into the blood

    • Early-phase trial
    • 29 healthy volunteers

    In an early test with 29 healthy volunteers, a blood-pressure drug combined with whole-body vibration raised Alzheimer's-linked beta-amyloid in the blood, a hint of sleep-like brain clearance that has not been tested on memory or dementia.

    Nature Communications
  2. Breast MRI found more early cancers, not fewer advanced ones

    • Observational study
    • 105,532 women

    Compared with matched mammograms, screening MRI found several times more early-stage cancers and far more false-alarm biopsy recommendations, yet did not lower advanced cancer rates overall in this non-randomized study.

    JAMA Network Open
  3. GLP-1 drugs and cancer depend on the comparison

    • Observational study
    • 359,595 adults with type 2 diabetes in the source population

    In one health system's records, GLP-1 drug users had fewer obesity-related cancers than insulin or sulfonylurea users but no clear difference from metformin, SGLT2 or DPP-4 inhibitor users, and the design cannot prove prevention.

    JAMA Network Open
  4. An AI that reads health clues from walking

    • Observational study
    • 3,328 adults

    A model trained on 3D skeletal motion from a deeply studied Israeli cohort predicted traits from metabolic health to frailty beyond what age and body size explained, though using it on everyday video is untested.

    Nature Medicine
  5. One in four teens had no active hour last week

    • Observational study

    A WHO-led pooling of self-reported surveys from more than 3.2 million adolescents in 140 countries found about a quarter had no day with an hour of activity in the past week, with girls behind boys and no change in 15 years.

    The University of Western Australia

The bedtime and radon findings both end in the same place: a link that now needs a direct test. We'll watch for who runs it. See you next week.

Get the next issue by email

Our weekly newsletter on what is new in health research, explained for curious readers and linked to the original studies. One email a week.

Sources

Source titles are preserved as published.

  1. Drug Therapies and Incidence of Dementia Among Adults With Overactive Bladder · JAMA Network Open
  2. Newer Overactive Bladder Drugs Were Not Linked to Lower Dementia Risk Than Oxybutynin · Medical Daily
  3. Indoor Radon and Incident Heart Failure Among Postmenopausal Women · JAMA Network Open
  4. High levels of indoor radon linked to higher risk of heart failure in postmenopausal women · Medical Xpress
  5. Prepare for responsive management or renal dialysis in older people living with kidney failure and frailty or multimorbidity (Prepare for Kidney Care): a multi-centre, randomised, unblinded, phase 3, superiority trial · The Lancet
  6. Dialysis may not be the default treatment for older kidney patients · News-Medical
  7. Kidney care trial challenges default dialysis planning for older adults with frailty · Medical Xpress
  8. Randomized Controlled Trial of Lifestyle Plus Sleep Extension Intervention on Adults With Prediabetes and Short Sleep · Nursing Research
  9. Earlier bedtime linked to weight loss in prediabetes · EurekAlert! (NYU Rory Meyers College of Nursing)
  10. Weight loss is tied to earlier bedtime, not the hours spent asleep · New Atlas
  11. Vasomechanic treatment is associated with increased efflux of human brain proteins · Nature Communications
  12. Blood pressure medication and vibration may boost brain waste clearance · Medical Xpress
  13. Novel treatment clears dementia-linked proteins from the waking brain · News-Medical
  14. A functional connectome identifies vulnerability to cognitive decline and Alzheimer's disease progression · Science Advances
  15. Stanford Medicine news release on brain activity patterns, super agers and Alzheimer's risk · EurekAlert! (Stanford Medicine)
  16. Brain activity patterns may predict Alzheimer's years before memory slips · Medical Xpress
  17. Opposing microbiome-mediated axes link modifiable lifestyles to health and chronic diseases · Nature Medicine
  18. Tokyo Medical University press release: two contrasting microbiome-mediated axes linking lifestyle with health and chronic disease (Japanese 4D cohort, about 6,800 people) · Tokyo Medical University via Digital PR Platform
  19. GLP-1 Receptor Agonists and Obesity-Related Cancer by Diabetes Severity · JAMA Network Open
  20. GLP-1 Diabetes Drugs Tied to 38% Lower Obesity-Related Cancer Risk Than Insulin, but No Clear Edge Over Metformin · Medical Daily
  21. Global adolescent physical activity estimates, 2010–2025 (The Lancet Global Health) · The Lancet Global Health
  22. Global call to get more adolescents moving · The University of Western Australia
  23. A gait foundation model for prediction of multisystem health phenotypes from 3D skeletal motion · Nature Medicine
  24. A Gait Foundation Model Predicts Multi-System Health Phenotypes from 3D Skeletal Motion (preprint) · arXiv
  25. Magnetic Resonance Imaging and Mammography Outcomes by Advanced Breast Cancer Risk · JAMA Network Open
  26. Reproductive span, hormone use and brain small-vessel health in 70-year-old women (Neurology) · Neurology
  27. Longer estrogen exposure linked to better brain vessel health in older women · Medical Xpress

Reference Range Weekly is for general information. It does not provide medical advice, diagnosis, or treatment.